falsefalse

My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer - Episode 7

Considerations for Treatment Selection for Patients with Disease Progression on Radium-223

,

A medical oncologist and radiation oncologist share clinical insight on how they might approach subsequent treatment selection in patients with mCRPC who have disease progression on or after radium-223.

Current Time 0:00
Duration 4:44
Loaded: 0%
Stream Type LIVE
Remaining Time 4:44
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
EP. 1: The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
EP. 2: Approved Treatment Options for Patients with mCRPC
EP. 3: Patient Profile: A 78-Year-Old Man with mCRPC
EP. 4: Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy
EP. 5: Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases
EP. 6: Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC
Now Viewing
EP. 7: Considerations for Treatment Selection for Patients with Disease Progression on Radium-223
EP. 8: Patient Profile: A 67-Year-Old Man with mCRPC and Asymptomatic Bone Metastases
EP. 9: Symptomatic Status and Lesion Size of Bone Metastases: Impact on Radiotherapy Selection in mCRPC
EP. 10: Closing Thoughts on the Future of mCRPC Treatment

Related Content:

My Treatment Approach: Metastatic Castration-Resistant Prostate CancerProstate CancerInsights
PSMAfore Data Drive Expanded Approval of Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC
Optimal Strategies for Navigating Referral and Bridging Therapy for CAR T-Cell Therapy in R/R DLBCL Patients
Practical Realities of CAR T-Cell Therapy for R/R DLBCL: Challenges and Lessons From the Community
x